{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:13:55Z","timestamp":1774714435018,"version":"3.50.1"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2019,12,1]]},"DOI":"10.1001\/jamaoto.2019.1012","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:30:52Z","timestamp":1556796652000},"page":"1121","source":"Crossref","is-referenced-by-count":7,"title":["Risk of Head and Neck Cancer in Patients With Prior Hematologic Malignant Tumors"],"prefix":"10.1001","volume":"145","author":[{"given":"Alia","family":"Mowery","sequence":"first","affiliation":[{"name":"School of Medicine, Oregon Health and Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Conlin","sequence":"additional","affiliation":[{"name":"Operative Care Division, Portland Veterans Affairs Health Care System, Portland, Oregon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Clayburgh","sequence":"additional","affiliation":[{"name":"Operative Care Division, Portland Veterans Affairs Health Care System, Portland, Oregon"},{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Oregon Health and Science University, Portland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"ooi190022r3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bjoms.2011.08.012","article-title":"Second primary head and neck squamous cell cancers with aggressive behavior in patients with chronic myeloid leukaemia.","volume":"50","author":"Budrukkar","year":"2012","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"10","key":"ooi190022r4","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3324\/haematol.2017.167478","article-title":"Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.","volume":"102","author":"Eichenauer","year":"2017","journal-title":"Haematologica"},{"issue":"9","key":"ooi190022r5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clml.2017.06.028","article-title":"Risk of second primary malignancies in patients with follicular lymphoma: a United States population-based study.","volume":"17","author":"Giri","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"ooi190022r6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/jnci\/djk030","article-title":"Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.","volume":"99","author":"Hisada","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"ooi190022r7","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1200\/JCO.2005.04.2200","article-title":"Risk of second malignancy after non-Hodgkin\u2019s lymphoma: a British cohort study.","volume":"24","author":"Mudie","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"ooi190022r8","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.19","article-title":"Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics.","volume":"3","author":"Razavi","year":"2013","journal-title":"Blood Cancer J"},{"issue":"26","key":"ooi190022r9","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma.","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"ooi190022r10","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1182\/blood.V98.6.1979","article-title":"Solid tumors after chronic lymphocytic leukemia.","volume":"98","author":"Hisada","year":"2001","journal-title":"Blood"},{"issue":"4","key":"ooi190022r11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1600-0609.1994.tb00192.x","article-title":"Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia.","volume":"53","author":"Mellemgaard","year":"1994","journal-title":"Eur J Haematol"},{"issue":"33","key":"ooi190022r12","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1200\/JCO.2010.29.1112","article-title":"Second malignancy risks after non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.","volume":"28","author":"Morton","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"ooi190022r13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Risk of second cancer after chronic lymphocytic leukemia.","volume":"121","author":"Sch\u00f6llkopf","year":"2007","journal-title":"Int J Cancer"},{"issue":"18","key":"ooi190022r14","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/jnci\/84.18.1422","article-title":"Second cancers in patients with chronic lymphocytic leukemia.","volume":"84","author":"Travis","year":"1992","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"ooi190022r15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1200\/JCO.2008.17.5398","article-title":"Other malignancies in chronic lymphocytic leukemia\/small lymphocytic lymphoma.","volume":"27","author":"Tsimberidou","year":"2009","journal-title":"J Clin Oncol"},{"issue":"23","key":"ooi190022r16","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.2217\/fon.15.252","article-title":"Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.","volume":"11","author":"Adhikari","year":"2015","journal-title":"Future Oncol"},{"issue":"4","key":"ooi190022r17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/bmt.2010.163","article-title":"High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.","volume":"46","author":"Chen","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"ooi190022r18","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2006.08.9276","article-title":"Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.","volume":"25","author":"Cohen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"13","key":"ooi190022r19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation.","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"ooi190022r20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11864-018-0528-y","article-title":"Second malignancies after hematopoietic stem cell transplantation.","volume":"19","author":"Danylesko","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"7","key":"ooi190022r21","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/bjc.2011.313","article-title":"Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.","volume":"105","author":"Royle","year":"2011","journal-title":"Br J Cancer"},{"issue":"3","key":"ooi190022r22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11864-004-0013-7","article-title":"Second neoplasms in patients with chronic lymphocytic leukemia.","volume":"5","author":"Wiernik","year":"2004","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"ooi190022r23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/(ISSN)1097-0142","article-title":"The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.","volume":"107","author":"Tward","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"ooi190022r24","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/cncr.29231","article-title":"Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.","volume":"121","author":"Chowdhry","year":"2015","journal-title":"Cancer"},{"issue":"5","key":"ooi190022r25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hed.v35.5","article-title":"Secondary head and neck cancer in patients with history of hematological malignancy.","volume":"35","author":"Chung","year":"2013","journal-title":"Head Neck"},{"issue":"7","key":"ooi190022r26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1377\/hlthaff.2014.0054","article-title":"Insights from advanced analytics at the Veterans Health Administration.","volume":"33","author":"Fihn","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"ooi190022r29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/jnci\/djk180","article-title":"Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.","volume":"99","author":"Maule","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"ooi190022r30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation.","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"issue":"7","key":"ooi190022r31","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1172\/JCI90599","article-title":"Immunotherapy for transplantation-associated viral infections.","volume":"127","author":"Roddie","year":"2017","journal-title":"J Clin Invest"},{"issue":"19","key":"ooi190022r32","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer.","volume":"356","author":"D\u2019Souza","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"ooi190022r33","first-page":"35","article-title":"Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia.","volume":"9","author":"Dasanu","year":"2007","journal-title":"MedGenMed"},{"issue":"4","key":"ooi190022r34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/10428194.2016.1217527","article-title":"Secondary malignancies in patients with multiple myeloma, Waldenstr\u00f6m macroglobulinemia and monoclonal gammopathy of undetermined significance.","volume":"58","author":"Castillo","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"ooi190022r35","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/cncr.v113:11","article-title":"Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis.","volume":"113","author":"Boukheris","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"ooi190022r36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1667\/RR3605.1","article-title":"Thyroid cancer in childhood cancer survivors: a detailed evaluation of radiation dose response and its modifiers.","volume":"166","author":"Ronckers","year":"2006","journal-title":"Radiat Res"},{"issue":"5","key":"ooi190022r37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/13547501003797664","article-title":"Polymorphisms in DNA damage response genes and head and neck cancer risk.","volume":"15","author":"Flores-Obando","year":"2010","journal-title":"Biomarkers"},{"issue":"10","key":"ooi190022r38","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1182\/blood-2002-04-1152","article-title":"The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia.","volume":"100","author":"Seedhouse","year":"2002","journal-title":"Blood"},{"key":"ooi190022r1","volume-title":"Cancer Facts & Figures 2019","author":"American Cancer Society","year":"2019"},{"key":"ooi190022r2","volume-title":"SEER Cancer Statistics Review, 1975-2014","author":"Howlader","year":"2017"},{"key":"ooi190022r28","volume-title":"Ascertaining Veterans\u2019 Vital Status: VA Data Sources for Mortality Ascertainment and Cause of Death. Database & Methods Cyberseminar Series","author":"Maynard","year":"2017"},{"key":"ooi190022r27","unstructured":"Centers for Disease Control and Prevention. Alcohol Related Disease Impact (ARDI) Application. 2013. https:\/\/nccd.cdc.gov\/DPH_ARDI\/default\/default.aspx. Accessed November 28, 2018."}],"container-title":["JAMA Otolaryngology\u2013Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2732848\/jamaotolaryngology_mowery_2019_oi_190022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T16:22:32Z","timestamp":1576772552000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2732848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2019.1012","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,1]]}}}